FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.8.2  |  FHIR Version n/a  User: [n/a]

422988009: Bismuth biskalcitrate (substance)


Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2007. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
2640344010 Bismuth biskalcitrate (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
2644399011 Bismuth biskalcitrate en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
3234001000005114 bismuthbiskalcitrat da Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) Danish module (core metadata concept)


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Bismuth biskalcitrate (substance) Is a Bismuth compound true Inferred relationship Some
Bismuth biskalcitrate (substance) Is a Antacid (substance) true Inferred relationship Some

Inbound Relationships Type Active Source Characteristic Refinability Group
Product containing bismuth biskalcitrate and metronidazole and tetracycline (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Bismuth biskalcitrate (substance) Inferred relationship Some 3
Product containing bismuth biskalcitrate (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Bismuth biskalcitrate (substance) Inferred relationship Some 1
bismuthbiskalcitrat 140 mg + metronidazol 125 mg + tetracyclin 125 mg kapsel The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Bismuth biskalcitrate (substance) Inferred relationship Some
bismuthbiskalcitrat 140 mg + metronidazol 125 mg + tetracyclin 125 mg kapsel This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. False Bismuth biskalcitrate (substance) Inferred relationship Some 2
bismuthbiskalcitrat 140 mg + metronidazol 125 mg + tetracyclin 125 mg kapsel The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Bismuth biskalcitrate (substance) Inferred relationship Some 3
bismuthbiskalcitrat 140 mg + metronidazol 125 mg + tetracyclin 125 mg kapsel This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. False Bismuth biskalcitrate (substance) Inferred relationship Some 3
bismuthbiskalcitrat 140 mg + metronidazol 125 mg + tetracyclin 125 mg kapsel The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). False Bismuth biskalcitrate (substance) Inferred relationship Some 2
Product containing bismuth biskalcitrate and metronidazole and tetracycline in oral dose form (medicinal product form) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Bismuth biskalcitrate (substance) Inferred relationship Some 3
Product containing only bismuth biskalcitrate (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Bismuth biskalcitrate (substance) Inferred relationship Some 1
Product containing only bismuth biskalcitrate and metronidazole and tetracycline (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Bismuth biskalcitrate (substance) Inferred relationship Some 3
Bismuth biskalcitrate and metronidazole and tetracycline only product in oral dose form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Bismuth biskalcitrate (substance) Inferred relationship Some 3
bismuthbiskalcitrat 140 mg + metronidazol 125 mg + tetracyclin 125 mg kapsel The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). False Bismuth biskalcitrate (substance) Inferred relationship Some 3
Bismuth biskalcitrate 140 mg and metronidazole 125 mg and tetracycline hydrochloride 125 mg oral capsule The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Bismuth biskalcitrate (substance) Inferred relationship Some 3
Bismuth biskalcitrate 140 mg and metronidazole 125 mg and tetracycline hydrochloride 125 mg oral capsule This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Bismuth biskalcitrate (substance) Inferred relationship Some 3

This concept is not in any reference sets

Back to Start